Management of immune cytopenias in patients with systemic lupus erythematosus - Old and new
- PMID: 23462431
- DOI: 10.1016/j.autrev.2013.02.001
Management of immune cytopenias in patients with systemic lupus erythematosus - Old and new
Abstract
There are various immune cytopenias associated with systemic lupus erythematosus (SLE). The most common one is anemia; however, there are different etiologies for the anemia caused by SLE. Anemia could be due to chronic disease, secondary to renal insufficiency, blood loss, drug induced or autoimmune hemolysis. There are other very rare causes of anemia secondary to SLE which include red cell aplasia, aplastic anemia, and microangiopathic hemolytic anemia. Treatment of the anemia would be according to the cause. Leukopenia, neutropenia, and lymphopenia are hematologic complications associated with SLE, and in majority of cases no treatment is required. Thrombocytopenia is one of the complications of SLE and is usually treated by steroids. However, there are significant numbers of patients which will either not respond to or relapse after treatment. This article summarizes immune cytopenias seen in patients with SLE, and it also discusses management of these cytopenias.
Copyright © 2013 Elsevier B.V. All rights reserved.
Similar articles
-
Splenectomy for cytopenias associated with systemic lupus erythematosus.Am J Surg. 1988 Mar;155(3):391-4. doi: 10.1016/s0002-9610(88)80097-7. Am J Surg. 1988. PMID: 3344900
-
Clinical assessment and management of cytopenias in lupus patients.Curr Rheumatol Rep. 2011 Aug;13(4):291-9. doi: 10.1007/s11926-011-0179-5. Curr Rheumatol Rep. 2011. PMID: 21503695 Review.
-
[Hematologic changes in systemic lupus erythematosus].Zhonghua Nei Ke Za Zhi. 1986 Jan;25(1):47-50. Zhonghua Nei Ke Za Zhi. 1986. PMID: 3525035 Review. Chinese. No abstract available.
-
Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.Am J Hematol. 2018 Mar;93(3):424-429. doi: 10.1002/ajh.24999. Epub 2018 Jan 25. Am J Hematol. 2018. PMID: 29247540
-
The management of peripheral blood cytopenias in systemic lupus erythematosus.Rheumatology (Oxford). 2010 Dec;49(12):2243-54. doi: 10.1093/rheumatology/keq269. Epub 2010 Sep 7. Rheumatology (Oxford). 2010. PMID: 20823093 Review.
Cited by
-
Mixed autoimmune hemolytic anemia as the initial presentation of systemic lupus erythematosus: A case report and review.EJHaem. 2024 Sep 11;5(5):1053-1056. doi: 10.1002/jha2.1008. eCollection 2024 Oct. EJHaem. 2024. PMID: 39415922 Free PMC article.
-
Evaluation of disease activity in systemic lupus erythematosus using standard deviation of lymphocyte volume combined with red blood cell count and lymphocyte percentage.Sci Rep. 2024 Sep 28;14(1):22470. doi: 10.1038/s41598-024-72977-w. Sci Rep. 2024. PMID: 39341869 Free PMC article.
-
Advances in Systemic Lupus Erythematosus Treatment With Monoclonal Antibodies: A Mini-Review.Cureus. 2024 Jul 8;16(7):e64090. doi: 10.7759/cureus.64090. eCollection 2024 Jul. Cureus. 2024. PMID: 39114252 Free PMC article. Review.
-
Systemic Immune-Inflammation Index as a Potential Biomarker for Assessing Disease Activity and Predicting Proteinuria Development in Systemic Lupus Erythematosus.Cureus. 2024 Jun 28;16(6):e63401. doi: 10.7759/cureus.63401. eCollection 2024 Jun. Cureus. 2024. PMID: 39070439 Free PMC article.
-
A systematic review and meta-analysis of the diagnostic accuracy of the neutrophil-to-lymphocyte ratio and the platelet-to-lymphocyte ratio in systemic lupus erythematosus.Clin Exp Med. 2024 Jul 25;24(1):170. doi: 10.1007/s10238-024-01438-5. Clin Exp Med. 2024. PMID: 39052098 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
